社区
首页
集团介绍
社区
资讯
行情
学堂
TigerGPT
登录
注册
honglilim
IP属地:未知
+关注
帖子 · 20
帖子 · 20
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
honglilim
honglilim
·
2021-06-07
Ok
非常抱歉,此主贴已删除
看
793
回复
1
点赞
2
编组 21备份 2
分享
举报
honglilim
honglilim
·
2021-06-06
Wow
非常抱歉,此主贴已删除
看
706
回复
1
点赞
3
编组 21备份 2
分享
举报
honglilim
honglilim
·
2021-06-04
Oo
非常抱歉,此主贴已删除
看
449
回复
1
点赞
3
编组 21备份 2
分享
举报
honglilim
honglilim
·
2021-06-02
Wow
非常抱歉,此主贴已删除
看
408
回复
1
点赞
2
编组 21备份 2
分享
举报
honglilim
honglilim
·
2021-05-31
Wow
非常抱歉,此主贴已删除
看
678
回复
评论
点赞
1
编组 21备份 2
分享
举报
honglilim
honglilim
·
2021-05-29
Zz
非常抱歉,此主贴已删除
看
628
回复
2
点赞
2
编组 21备份 2
分享
举报
honglilim
honglilim
·
2021-05-25
Comment like
非常抱歉,此主贴已删除
看
589
回复
1
点赞
5
编组 21备份 2
分享
举报
honglilim
honglilim
·
2021-05-24
Comment
ZipRecruiter Is Going Public This Month. What to Know.
ZipRecruiter, the latest company to file for a direct listing, has set a date for its offering.The o
ZipRecruiter Is Going Public This Month. What to Know.
看
662
回复
1
点赞
2
编组 21备份 2
分享
举报
honglilim
honglilim
·
2021-05-24
Likee
Why Cathie Wood Is Bullish On Iovance Biotherapeutics (IOVA)
Cathie Wood-led Ark Investment Management is betting that despite recent setbacks Iovance Biotherape
Why Cathie Wood Is Bullish On Iovance Biotherapeutics (IOVA)
看
896
回复
3
点赞
3
编组 21备份 2
分享
举报
honglilim
honglilim
·
2021-05-23
Like pls
非常抱歉,此主贴已删除
看
490
回复
4
点赞
2
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3581928095976339","uuid":"3581928095976339","gmtCreate":1619681778701,"gmtModify":1620637243387,"name":"honglilim","pinyin":"honglilim","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/6293fa1ee1847bbc106832041ec44a61","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":3,"headSize":61,"tweetSize":20,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖(非转发)","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.17","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.48%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":114952707,"gmtCreate":1623044917709,"gmtModify":1634095891931,"author":{"id":"3581928095976339","authorId":"3581928095976339","name":"honglilim","avatar":"https://static.tigerbbs.com/6293fa1ee1847bbc106832041ec44a61","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581928095976339","authorIdStr":"3581928095976339"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/114952707","repostId":"2141280370","repostType":4,"isVote":1,"tweetType":1,"viewCount":793,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":115187538,"gmtCreate":1622959415024,"gmtModify":1634096558414,"author":{"id":"3581928095976339","authorId":"3581928095976339","name":"honglilim","avatar":"https://static.tigerbbs.com/6293fa1ee1847bbc106832041ec44a61","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581928095976339","authorIdStr":"3581928095976339"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/115187538","repostId":"1102972710","repostType":4,"isVote":1,"tweetType":1,"viewCount":706,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":116952635,"gmtCreate":1622771138527,"gmtModify":1634098179960,"author":{"id":"3581928095976339","authorId":"3581928095976339","name":"honglilim","avatar":"https://static.tigerbbs.com/6293fa1ee1847bbc106832041ec44a61","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581928095976339","authorIdStr":"3581928095976339"},"themes":[],"htmlText":"Oo","listText":"Oo","text":"Oo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/116952635","repostId":"1106261871","repostType":4,"isVote":1,"tweetType":1,"viewCount":449,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":113807391,"gmtCreate":1622601035113,"gmtModify":1634100036924,"author":{"id":"3581928095976339","authorId":"3581928095976339","name":"honglilim","avatar":"https://static.tigerbbs.com/6293fa1ee1847bbc106832041ec44a61","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581928095976339","authorIdStr":"3581928095976339"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/113807391","repostId":"1175551284","repostType":4,"isVote":1,"tweetType":1,"viewCount":408,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":110804396,"gmtCreate":1622435680915,"gmtModify":1634101483076,"author":{"id":"3581928095976339","authorId":"3581928095976339","name":"honglilim","avatar":"https://static.tigerbbs.com/6293fa1ee1847bbc106832041ec44a61","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581928095976339","authorIdStr":"3581928095976339"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/110804396","repostId":"2139872224","repostType":4,"isVote":1,"tweetType":1,"viewCount":678,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":137979443,"gmtCreate":1622292107182,"gmtModify":1634102484537,"author":{"id":"3581928095976339","authorId":"3581928095976339","name":"honglilim","avatar":"https://static.tigerbbs.com/6293fa1ee1847bbc106832041ec44a61","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581928095976339","authorIdStr":"3581928095976339"},"themes":[],"htmlText":"Zz","listText":"Zz","text":"Zz","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/137979443","repostId":"2138948877","repostType":4,"isVote":1,"tweetType":1,"viewCount":628,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":138281553,"gmtCreate":1621943086672,"gmtModify":1634185307423,"author":{"id":"3581928095976339","authorId":"3581928095976339","name":"honglilim","avatar":"https://static.tigerbbs.com/6293fa1ee1847bbc106832041ec44a61","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581928095976339","authorIdStr":"3581928095976339"},"themes":[],"htmlText":"Comment like","listText":"Comment like","text":"Comment like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/138281553","repostId":"2138164416","repostType":4,"isVote":1,"tweetType":1,"viewCount":589,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":131628691,"gmtCreate":1621857237813,"gmtModify":1634186063710,"author":{"id":"3581928095976339","authorId":"3581928095976339","name":"honglilim","avatar":"https://static.tigerbbs.com/6293fa1ee1847bbc106832041ec44a61","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581928095976339","authorIdStr":"3581928095976339"},"themes":[],"htmlText":"Comment","listText":"Comment","text":"Comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/131628691","repostId":"1146017349","repostType":4,"repost":{"id":"1146017349","kind":"news","pubTimestamp":1621843320,"share":"https://www.laohu8.com/m/news/1146017349?lang=&edition=full","pubTime":"2021-05-24 16:02","market":"us","language":"en","title":"ZipRecruiter Is Going Public This Month. What to Know.","url":"https://stock-news.laohu8.com/highlight/detail?id=1146017349","media":"Barrons","summary":"ZipRecruiter, the latest company to file for a direct listing, has set a date for its offering.The o","content":"<p>ZipRecruiter, the latest company to file for a direct listing, has set a date for its offering.</p><p>The online employment marketplace said it would make its debut on the New York Stock Exchange “on or about May 26, 2021,” a prospectus said. It will trade under the symbol ZIP.</p><p>ZipRecruiter itself is not selling shares with the offering and will not receive proceeds from the direct listing. Instead, its shareholders will offer up to 86,598,896 shares of Class A common stock for resale, according to the document.</p><p>ZipRecruiter will be the third company this year to use a direct listing to go public:Coinbase(ticker: COIN), a cryptocurrency exchange, used the method to list its shares in April on the Nasdaq, after the gaming platform Roblox(RBLX) did so for its March debut on the NYSE. (Squarespace, a website design company,has also filed to go public via a direct listing on the NYSE, but has yet to set a trading date.)</p><p>Companies mainly use direct listings because they’re cheaper than traditional IPOs and allow shareholders to sell their stock to the public without intermediaries. In a traditional IPO, a company sells shares and uses an investment bank or banks to underwrite the deals. But in a direct listing, a bank or banks typically work as financial advisors for the company going public.</p><p>ZipRecruiter has lined up six investment banks—Goldman Sachs(GS),JPMorgan Chase(JPM), Barclays Capital,Evercore Group(EVR), William Blair and Raymond James—to advise on the upcoming offering. However, only Goldman and JPMorgan Chase will consult with a designated market maker to set ZipRecruiter’s opening price.</p><p>Direct listings typically do not include lockups, which prevent shareholders from selling for a certain period of time. ZipRecruiter stockholders, similarly, will be able to selltheir shares as soon as the company lists later this month.</p><p>In a traditional IPO, a company will have a roadshow where the management team makes presentations to institutional investors to create interest in the stock. Direct listings have replaced the roadshow with the investor day, when investors typically learn about a company going public via a webcast meeting. ZipRecruiter is hosting its investor day on May 10.</p><p>Founded in 2010, ZipRecruiter is an employment marketplace for people looking for work and businesses seeking employees. More than 2.8 million businesses have used ZipRecruiter to find an employee while 110 million jobseekers have sought employment on the site, the filing said. The company became profitable in 2020, reporting $86 million in income from $6.3 million in losses in 2019. Revenue droppednearly 3% to $418 million in 2020, the prospectus said.</p><p>ZipRecruiter has raised $219 million in funding, according to Crunchbase. This includes a $156 million round in 2018 co-led by Wellington Management Company and Institutional Venture Partners, or IVP. IVP owns the biggest chunk of ZipRecruiter’s voting power—21.1%.</p><p>Several shareholders have registered their class A common stock, which they may or may not sell via the direct listing, the prospectus said. IVP has registered about 22.7 million Class A shares, while Wellington is offering roughly 1.9 million shares. ZipRecruiter CEO Ian Siegel has put up 10.5 million Class A shares.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ZipRecruiter Is Going Public This Month. What to Know.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZipRecruiter Is Going Public This Month. What to Know.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-24 16:02 GMT+8 <a href=https://www.barrons.com/articles/ziprecruiter-direct-listing-what-to-know-51619903652?mod=RTA><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>ZipRecruiter, the latest company to file for a direct listing, has set a date for its offering.The online employment marketplace said it would make its debut on the New York Stock Exchange “on or ...</p>\n\n<a href=\"https://www.barrons.com/articles/ziprecruiter-direct-listing-what-to-know-51619903652?mod=RTA\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ZIP":"ZipRecruiter Inc."},"source_url":"https://www.barrons.com/articles/ziprecruiter-direct-listing-what-to-know-51619903652?mod=RTA","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1146017349","content_text":"ZipRecruiter, the latest company to file for a direct listing, has set a date for its offering.The online employment marketplace said it would make its debut on the New York Stock Exchange “on or about May 26, 2021,” a prospectus said. It will trade under the symbol ZIP.ZipRecruiter itself is not selling shares with the offering and will not receive proceeds from the direct listing. Instead, its shareholders will offer up to 86,598,896 shares of Class A common stock for resale, according to the document.ZipRecruiter will be the third company this year to use a direct listing to go public:Coinbase(ticker: COIN), a cryptocurrency exchange, used the method to list its shares in April on the Nasdaq, after the gaming platform Roblox(RBLX) did so for its March debut on the NYSE. (Squarespace, a website design company,has also filed to go public via a direct listing on the NYSE, but has yet to set a trading date.)Companies mainly use direct listings because they’re cheaper than traditional IPOs and allow shareholders to sell their stock to the public without intermediaries. In a traditional IPO, a company sells shares and uses an investment bank or banks to underwrite the deals. But in a direct listing, a bank or banks typically work as financial advisors for the company going public.ZipRecruiter has lined up six investment banks—Goldman Sachs(GS),JPMorgan Chase(JPM), Barclays Capital,Evercore Group(EVR), William Blair and Raymond James—to advise on the upcoming offering. However, only Goldman and JPMorgan Chase will consult with a designated market maker to set ZipRecruiter’s opening price.Direct listings typically do not include lockups, which prevent shareholders from selling for a certain period of time. ZipRecruiter stockholders, similarly, will be able to selltheir shares as soon as the company lists later this month.In a traditional IPO, a company will have a roadshow where the management team makes presentations to institutional investors to create interest in the stock. Direct listings have replaced the roadshow with the investor day, when investors typically learn about a company going public via a webcast meeting. ZipRecruiter is hosting its investor day on May 10.Founded in 2010, ZipRecruiter is an employment marketplace for people looking for work and businesses seeking employees. More than 2.8 million businesses have used ZipRecruiter to find an employee while 110 million jobseekers have sought employment on the site, the filing said. The company became profitable in 2020, reporting $86 million in income from $6.3 million in losses in 2019. Revenue droppednearly 3% to $418 million in 2020, the prospectus said.ZipRecruiter has raised $219 million in funding, according to Crunchbase. This includes a $156 million round in 2018 co-led by Wellington Management Company and Institutional Venture Partners, or IVP. IVP owns the biggest chunk of ZipRecruiter’s voting power—21.1%.Several shareholders have registered their class A common stock, which they may or may not sell via the direct listing, the prospectus said. IVP has registered about 22.7 million Class A shares, while Wellington is offering roughly 1.9 million shares. ZipRecruiter CEO Ian Siegel has put up 10.5 million Class A shares.","news_type":1},"isVote":1,"tweetType":1,"viewCount":662,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":131187794,"gmtCreate":1621836318818,"gmtModify":1634186200314,"author":{"id":"3581928095976339","authorId":"3581928095976339","name":"honglilim","avatar":"https://static.tigerbbs.com/6293fa1ee1847bbc106832041ec44a61","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581928095976339","authorIdStr":"3581928095976339"},"themes":[],"htmlText":"Likee","listText":"Likee","text":"Likee","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/131187794","repostId":"1185350425","repostType":4,"repost":{"id":"1185350425","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1621835821,"share":"https://www.laohu8.com/m/news/1185350425?lang=&edition=full","pubTime":"2021-05-24 13:57","market":"us","language":"en","title":"Why Cathie Wood Is Bullish On Iovance Biotherapeutics (IOVA)","url":"https://stock-news.laohu8.com/highlight/detail?id=1185350425","media":"Benzinga","summary":"Cathie Wood-led Ark Investment Management is betting that despite recent setbacks Iovance Biotherape","content":"<p>Cathie Wood-led Ark Investment Management is betting that despite recent setbacks <b>Iovance Biotherapeutics Inc</b> IOVA 3.73% will benefit from its compelling tumor-infiltrating lymphocyte (TIL) immunotherapy.</p><p><b>What Happened:</b> IOVA shares have declined 32% since Tuesday after the California-based biotech startup delayedits Biologics License Application (BLA) until the first half of 2022 because of FDA feedback on its potency tests.</p><p>The delay in the program is attributed to the FDA’s second request for additional data regarding potency assays, which are a series of tests that prove the company can consistently manufacture the product in question.</p><p>Soon after, IOVA announced CEO Maria Fardis is leaving the company after five years in the role and that General Counsel Frederick Vogt would be stepping in as interim CEO. Shares fell 39% on Wednesday after the announcement.</p><p>The New York-based investment firm started piling up shares in the company last week and holds 18.26 million IOVA shares, worth about $450.64 million, according to Ark’s data as of Friday’s trade.</p><p>The <b>Ark Genomic Revolution</b> ETF (BATS:ARKG) and the<b>Ark Innovation ETF</b> ARKK 0.75% carry the stake in IOVA.</p><p>“We believe that Iovance’s TILs will continue to be the most compelling therapy for solid tumors in the market and that Iovance has the most robust TIL data set,” the Cathie Wood-led firm said in a note to investors.</p><p>“Furthermore, in our view, Iovance is trail-blazing the FDA regulatory process and likely will get FDA approval for its TIL therapy to treat melanoma, a very difficult-to-treat disease with high unmet need.”</p><p><b>Price Action:</b> IOVA shares closed 3.73% lower at $18.05 on Friday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Cathie Wood Is Bullish On Iovance Biotherapeutics (IOVA)</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Cathie Wood Is Bullish On Iovance Biotherapeutics (IOVA)\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-05-24 13:57</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Cathie Wood-led Ark Investment Management is betting that despite recent setbacks <b>Iovance Biotherapeutics Inc</b> IOVA 3.73% will benefit from its compelling tumor-infiltrating lymphocyte (TIL) immunotherapy.</p><p><b>What Happened:</b> IOVA shares have declined 32% since Tuesday after the California-based biotech startup delayedits Biologics License Application (BLA) until the first half of 2022 because of FDA feedback on its potency tests.</p><p>The delay in the program is attributed to the FDA’s second request for additional data regarding potency assays, which are a series of tests that prove the company can consistently manufacture the product in question.</p><p>Soon after, IOVA announced CEO Maria Fardis is leaving the company after five years in the role and that General Counsel Frederick Vogt would be stepping in as interim CEO. Shares fell 39% on Wednesday after the announcement.</p><p>The New York-based investment firm started piling up shares in the company last week and holds 18.26 million IOVA shares, worth about $450.64 million, according to Ark’s data as of Friday’s trade.</p><p>The <b>Ark Genomic Revolution</b> ETF (BATS:ARKG) and the<b>Ark Innovation ETF</b> ARKK 0.75% carry the stake in IOVA.</p><p>“We believe that Iovance’s TILs will continue to be the most compelling therapy for solid tumors in the market and that Iovance has the most robust TIL data set,” the Cathie Wood-led firm said in a note to investors.</p><p>“Furthermore, in our view, Iovance is trail-blazing the FDA regulatory process and likely will get FDA approval for its TIL therapy to treat melanoma, a very difficult-to-treat disease with high unmet need.”</p><p><b>Price Action:</b> IOVA shares closed 3.73% lower at $18.05 on Friday.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"IOVA":"Iovance Biotherapeutics, Inc.","ARKK":"ARK Innovation ETF","ARKG":"ARK Genomic Revolution ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1185350425","content_text":"Cathie Wood-led Ark Investment Management is betting that despite recent setbacks Iovance Biotherapeutics Inc IOVA 3.73% will benefit from its compelling tumor-infiltrating lymphocyte (TIL) immunotherapy.What Happened: IOVA shares have declined 32% since Tuesday after the California-based biotech startup delayedits Biologics License Application (BLA) until the first half of 2022 because of FDA feedback on its potency tests.The delay in the program is attributed to the FDA’s second request for additional data regarding potency assays, which are a series of tests that prove the company can consistently manufacture the product in question.Soon after, IOVA announced CEO Maria Fardis is leaving the company after five years in the role and that General Counsel Frederick Vogt would be stepping in as interim CEO. Shares fell 39% on Wednesday after the announcement.The New York-based investment firm started piling up shares in the company last week and holds 18.26 million IOVA shares, worth about $450.64 million, according to Ark’s data as of Friday’s trade.The Ark Genomic Revolution ETF (BATS:ARKG) and theArk Innovation ETF ARKK 0.75% carry the stake in IOVA.“We believe that Iovance’s TILs will continue to be the most compelling therapy for solid tumors in the market and that Iovance has the most robust TIL data set,” the Cathie Wood-led firm said in a note to investors.“Furthermore, in our view, Iovance is trail-blazing the FDA regulatory process and likely will get FDA approval for its TIL therapy to treat melanoma, a very difficult-to-treat disease with high unmet need.”Price Action: IOVA shares closed 3.73% lower at $18.05 on Friday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":896,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":133219516,"gmtCreate":1621751707535,"gmtModify":1634186768134,"author":{"id":"3581928095976339","authorId":"3581928095976339","name":"honglilim","avatar":"https://static.tigerbbs.com/6293fa1ee1847bbc106832041ec44a61","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581928095976339","authorIdStr":"3581928095976339"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/133219516","repostId":"2137906121","repostType":4,"isVote":1,"tweetType":1,"viewCount":490,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":false}